Phase II study to evaluate the efficacy of Trastuzumab in combination with Capecitabine and Oxaliplatin in first-line treatment of HER2-positive advanced gastric cancer: HERXO trial

1. Rivera, F.
2. Romero, C.
3. Jimenez-Fonseca, P.
4. Izquierdo-Manuel, M.
5. Salud, A.
6. Martínez, E.
7. Jorge, M.
8. Arrazubi, V.
9. Méndez, J.C.
10. García-Alfonso, P.
11. Reboredo, M.
12. Barriuso, J.
13. Muñoz-Unceta, N.
14. Jimeno, R.
15. López, C.